BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29655283)

  • 1. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
    Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
    Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic Profiling of Peripheral B Cells in Antibody Positive Sjogren's Patients Reveals Interferon Signature.
    Maleki-Fischbach M; Anderson K; Fernández Pérez ER
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
    Brauner S; Folkersen L; Kvarnström M; Meisgen S; Petersen S; Franzén-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmström V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
    Ann Rheum Dis; 2017 Oct; 76(10):1755-1763. PubMed ID: 28760805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunological, and immunogenetic aspects of autoantibody production against Ro/SSA, La/SSB and their linear epitopes in primary Sjögren's syndrome (pSS): a European multicentre study.
    Tzioufas AG; Wassmuth R; Dafni UG; Guialis A; Haga HJ; Isenberg DA; Jonsson R; Kalden JR; Kiener H; Sakarellos C; Smolen JS; Sutcliffe N; Vitali C; Yiannaki E; Moutsopoulos HM
    Ann Rheum Dis; 2002 May; 61(5):398-404. PubMed ID: 11959762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.
    Aqrawi LA; Skarstein K; Øijordsbakken G; Brokstad KA
    Clin Exp Immunol; 2013 May; 172(2):228-37. PubMed ID: 23574319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptome Analysis of CCR9+ T Helper Cells From Primary Sjögren's Syndrome Patients Identifies CCL5 as a Novel Effector Molecule.
    Hinrichs AC; Blokland SLM; Lopes AP; Wichers CGK; Kruize AA; Pandit A; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():702733. PubMed ID: 34386009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
    Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
    Front Immunol; 2019; 10():2096. PubMed ID: 31552042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant cell signalling in PBMCs upon IFN-α stimulation in primary Sjögren's syndrome patients associates with type I interferon signature.
    Davies R; Hammenfors D; Bergum B; Vogelsang P; Gavasso S; Brun JG; Jonsson R; Appel S
    Eur J Immunol; 2018 Jul; 48(7):1217-1227. PubMed ID: 29604049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
    Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
    Front Immunol; 2021; 12():701656. PubMed ID: 34413853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
    Brkic Z; Maria NI; van Helden-Meeuwsen CG; van de Merwe JP; van Daele PL; Dalm VA; Wildenberg ME; Beumer W; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
    Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
    Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation.
    Rivière E; Pascaud J; Tchitchek N; Boudaoud S; Paoletti A; Ly B; Dupré A; Chen H; Thai A; Allaire N; Jagla B; Mingueneau M; Nocturne G; Mariette X
    Ann Rheum Dis; 2020 Nov; 79(11):1468-1477. PubMed ID: 32843324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren's syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14.
    Uomori K; Nozawa K; Ikeda K; Doe K; Yamada Y; Yamaguchi A; Fujishiro M; Kawasaki M; Morimoto S; Takamori K; Sekigawa I; Chan EK; Takasaki Y
    Autoimmunity; 2016 Aug; 49(5):347-56. PubMed ID: 27328271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
    Pertovaara M; Silvennoinen O; Isomäki P
    Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome.
    Sanosyan A; Daien C; Nutz A; Bollore K; Bedin AS; Morel J; Zimmermann V; Nocturne G; Peries M; Guigue N; Gottenberg JE; Van de Perre P; Mariette X; Tuaillon E
    Front Immunol; 2019; 10():1153. PubMed ID: 31191532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression profiling of epithelium-associated FcRL4
    Verstappen GM; Ice JA; Bootsma H; Pringle S; Haacke EA; de Lange K; van der Vries GB; Hickey P; Vissink A; Spijkervet FKL; Lessard CJ; Kroese FGM
    J Autoimmun; 2020 May; 109():102439. PubMed ID: 32201227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren's syndrome.
    Sun JL; Zhang HZ; Liu SY; Lian CF; Chen ZL; Shao TH; Zhang S; Zhao LL; He CM; Wang M; Zhang W; Chen H; Zhang FC
    Ann Rheum Dis; 2020 Apr; 79(4):518-524. PubMed ID: 32114510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
    Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4
    Hong X; Meng S; Tang D; Wang T; Ding L; Yu H; Li H; Liu D; Dai Y; Yang M
    Front Immunol; 2020; 11():594658. PubMed ID: 33603736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
    Li N; Li L; Wu M; Li Y; Yang J; Wu Y; Xu H; Luo D; Gao Y; Fei X; Jiang L
    Front Immunol; 2021; 12():697157. PubMed ID: 34367157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.